Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers
Main Author: | |
---|---|
Publication Date: | 2021 |
Other Authors: | , , , , , , |
Format: | Article |
Language: | eng |
Source: | Repositório Institucional da UNESP |
Download full: | http://dx.doi.org/10.1016/j.ejpb.2021.08.011 http://hdl.handle.net/11449/233458 |
Summary: | Glioblastoma multiforme (GBM) is the most common primary brain cancer. GBM has aggressive development, and the pharmacological treatment remains a challenge due to GBM anatomical characteristics’ (the blood–brain barrier and tumor microenvironment) and the increasing resistance to marketed drugs, such as temozolomide (TMZ), the first-line drug for GBM treatment. Due to physical–chemical properties such as short half-life time and the increasing resistance shown by GBM cells, high doses and repeated administrations are necessary, leading to significant adverse events. This review will discuss the main molecular mechanisms of TMZ resistance and the use of functionalized nanocarriers as an efficient and safe strategy for TMZ delivery. GBM-targeting nanocarriers are an important tool for the treatment of GBM, demonstrating to improve the biopharmaceutical properties of TMZ and repurpose its use in anti-GBM therapy. Technical aspects of nanocarriers will be discussed, and biological models highlighting the advantages and effects of functionalization strategies in TMZ anti-GBM activity. Finally, conclusions regarding the main findings will be made in the context of new perspectives for the treatment of GBM using TMZ as a chemotherapy agent, improving the sensibility and biological anti-tumor effect of TMZ through functionalization strategies. |
id |
UNSP_98f5fe332dc4c487eefd5318bdd9cd88 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/233458 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriersBrain cancerCancer therapyDrug resistanceFunctionalizationGlioblastomaNanotechnologyGlioblastoma multiforme (GBM) is the most common primary brain cancer. GBM has aggressive development, and the pharmacological treatment remains a challenge due to GBM anatomical characteristics’ (the blood–brain barrier and tumor microenvironment) and the increasing resistance to marketed drugs, such as temozolomide (TMZ), the first-line drug for GBM treatment. Due to physical–chemical properties such as short half-life time and the increasing resistance shown by GBM cells, high doses and repeated administrations are necessary, leading to significant adverse events. This review will discuss the main molecular mechanisms of TMZ resistance and the use of functionalized nanocarriers as an efficient and safe strategy for TMZ delivery. GBM-targeting nanocarriers are an important tool for the treatment of GBM, demonstrating to improve the biopharmaceutical properties of TMZ and repurpose its use in anti-GBM therapy. Technical aspects of nanocarriers will be discussed, and biological models highlighting the advantages and effects of functionalization strategies in TMZ anti-GBM activity. Finally, conclusions regarding the main findings will be made in the context of new perspectives for the treatment of GBM using TMZ as a chemotherapy agent, improving the sensibility and biological anti-tumor effect of TMZ through functionalization strategies.School of Pharmaceutical Sciences São Paulo State University (UNESP)Hematology and Transfusion Medicine Center University of Campinas (UNICAMP)School of Pharmaceutical Science of Ribeirão Preto University of São Paulo (USP)School of Pharmaceutical Sciences São Paulo State University (UNESP)Universidade Estadual Paulista (UNESP)Universidade Estadual de Campinas (UNICAMP)Universidade de São Paulo (USP)Delello Di Filippo, Leonardo [UNESP]Hofstätter Azambuja, JulianaPaes Dutra, Jessyca Aparecida [UNESP]Tavares Luiz, MarcelaLobato Duarte, Jonatas [UNESP]Nicoleti, Luiza Ribeiro [UNESP]Olalla Saad, Sara TeresinhaChorilli, Marlus [UNESP]2022-05-01T08:44:46Z2022-05-01T08:44:46Z2021-11-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article76-89http://dx.doi.org/10.1016/j.ejpb.2021.08.011European Journal of Pharmaceutics and Biopharmaceutics, v. 168, p. 76-89.1873-34410939-6411http://hdl.handle.net/11449/23345810.1016/j.ejpb.2021.08.0112-s2.0-85113951060Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengEuropean Journal of Pharmaceutics and Biopharmaceuticsinfo:eu-repo/semantics/openAccess2025-03-29T05:16:08Zoai:repositorio.unesp.br:11449/233458Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462025-03-29T05:16:08Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers |
title |
Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers |
spellingShingle |
Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers Delello Di Filippo, Leonardo [UNESP] Brain cancer Cancer therapy Drug resistance Functionalization Glioblastoma Nanotechnology |
title_short |
Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers |
title_full |
Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers |
title_fullStr |
Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers |
title_full_unstemmed |
Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers |
title_sort |
Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers |
author |
Delello Di Filippo, Leonardo [UNESP] |
author_facet |
Delello Di Filippo, Leonardo [UNESP] Hofstätter Azambuja, Juliana Paes Dutra, Jessyca Aparecida [UNESP] Tavares Luiz, Marcela Lobato Duarte, Jonatas [UNESP] Nicoleti, Luiza Ribeiro [UNESP] Olalla Saad, Sara Teresinha Chorilli, Marlus [UNESP] |
author_role |
author |
author2 |
Hofstätter Azambuja, Juliana Paes Dutra, Jessyca Aparecida [UNESP] Tavares Luiz, Marcela Lobato Duarte, Jonatas [UNESP] Nicoleti, Luiza Ribeiro [UNESP] Olalla Saad, Sara Teresinha Chorilli, Marlus [UNESP] |
author2_role |
author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Estadual Paulista (UNESP) Universidade Estadual de Campinas (UNICAMP) Universidade de São Paulo (USP) |
dc.contributor.author.fl_str_mv |
Delello Di Filippo, Leonardo [UNESP] Hofstätter Azambuja, Juliana Paes Dutra, Jessyca Aparecida [UNESP] Tavares Luiz, Marcela Lobato Duarte, Jonatas [UNESP] Nicoleti, Luiza Ribeiro [UNESP] Olalla Saad, Sara Teresinha Chorilli, Marlus [UNESP] |
dc.subject.por.fl_str_mv |
Brain cancer Cancer therapy Drug resistance Functionalization Glioblastoma Nanotechnology |
topic |
Brain cancer Cancer therapy Drug resistance Functionalization Glioblastoma Nanotechnology |
description |
Glioblastoma multiforme (GBM) is the most common primary brain cancer. GBM has aggressive development, and the pharmacological treatment remains a challenge due to GBM anatomical characteristics’ (the blood–brain barrier and tumor microenvironment) and the increasing resistance to marketed drugs, such as temozolomide (TMZ), the first-line drug for GBM treatment. Due to physical–chemical properties such as short half-life time and the increasing resistance shown by GBM cells, high doses and repeated administrations are necessary, leading to significant adverse events. This review will discuss the main molecular mechanisms of TMZ resistance and the use of functionalized nanocarriers as an efficient and safe strategy for TMZ delivery. GBM-targeting nanocarriers are an important tool for the treatment of GBM, demonstrating to improve the biopharmaceutical properties of TMZ and repurpose its use in anti-GBM therapy. Technical aspects of nanocarriers will be discussed, and biological models highlighting the advantages and effects of functionalization strategies in TMZ anti-GBM activity. Finally, conclusions regarding the main findings will be made in the context of new perspectives for the treatment of GBM using TMZ as a chemotherapy agent, improving the sensibility and biological anti-tumor effect of TMZ through functionalization strategies. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-11-01 2022-05-01T08:44:46Z 2022-05-01T08:44:46Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1016/j.ejpb.2021.08.011 European Journal of Pharmaceutics and Biopharmaceutics, v. 168, p. 76-89. 1873-3441 0939-6411 http://hdl.handle.net/11449/233458 10.1016/j.ejpb.2021.08.011 2-s2.0-85113951060 |
url |
http://dx.doi.org/10.1016/j.ejpb.2021.08.011 http://hdl.handle.net/11449/233458 |
identifier_str_mv |
European Journal of Pharmaceutics and Biopharmaceutics, v. 168, p. 76-89. 1873-3441 0939-6411 10.1016/j.ejpb.2021.08.011 2-s2.0-85113951060 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
European Journal of Pharmaceutics and Biopharmaceutics |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
76-89 |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
repositoriounesp@unesp.br |
_version_ |
1834482500313808896 |